Lung CD57 + cell density is increased in very severe COPD

Histology and Histopathology

Volumn 27, Issue 1, 2012, Pages 39-47

  Olloquequi, Jordi ^a   García Valero, José ^a   Rodríguez, Esther ^b,c   Montero, M Angeles ^b   Ferrer, Jaume ^b,c   Montes, Juan F ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cigarette smoking; Cytolytic cells; Immunohistochemistry; Lung inflammation

Indexed keywords

CD57 ANTIGEN;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG; MALE; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PATHOPHYSIOLOGY; SPAIN; UPREGULATION;

AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD57; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPAIN; UP-REGULATION;

EID: 82755196325     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Abo T. and Balch C.M. (1981). A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol. 127, 1024-1029.
2. Andersson C.K., Mori M., Bjermer L., Löfdahl C.G. and Erjefält J.S. (2010). Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 181, 206-217.
3. Baraldo S., Turato G., Badin C., Bazzan E., Beghé B., Zuin R., Calabrese F., Casoni G., Maestrelli P., Papi A., Fabbri LM. and Saetta M. (2004). Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax 59, 308-312.
4. Barnes P.J. and Cosío M.G. (2006). Cells and mediators of chronic obstructive pulmonary disease. In: Management of chronic obstructive pulmonary disease. European Respiratory Monograph 38. Siafakas N.M. (ed). Wakefield. UK. pp 130-158.
5. Bosken C.H., Hards J., Gatter K. and Hogg J.C. (1992). Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am. Rev. Respir. Dis. 145, 911-917.
6. Brenchley J.M., Karandikar N.J., Betts M.R., Ambrozak D.R., Hill B.J., Crotty L.E., Casazza J.P., Kuruppu J., Migueles S.A., Connors M., Roederer M., Douek D.C. and Koup R.A. (2003). Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101, 2711-2720.
7. Chattopadhyay P.K., Betts M.R., Price D.A., Gostick E., Horton H., Roederer M. and De Rosa S.C. (2009). The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J. Leukoc. Biol. 85, 88-97.
8. Cox G. and Austin R.C. (1997). Dexamethasone-induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis. J. Leukoc. Biol. 61, 224-230.
9. Crapo R., Hankinson J., Irvin C., MacIntre N., Voter K. and Wise R. Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (1995). Standardization of Spirometry, 1994 Update. American Thoracic Society. Am. J. Respir. Crit. Care. Med. 152, 1107-1136.
10. Di Girolamo W., Coronato S., Portiansky E. and Laguens G. (2008). Profile of immune cells in lymph nodes draining human malignant tumors. Medicina (B Aires). 68, 423-427.
11. Di Stefano A., Capelli A., Lusuardi M., Balbo P., Vecchio C., Maestrelli P., Mapp C.E., Fabbri L.M., Donner C.F. and Saetta M. (1998). Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am. J. Respir. Crit. Care. Med. 158, 1277-1285.
12. Di Stefano A., Caramori G., Gnemmi I., Contoli M., Bristot L., Capelli A., Ricciardolo F.L., Magno F., D'Anna S.E., Zanini A., Carbone M., Sabatini F., Usai C., Brun P., Chung K.F., Barnes P.J., Papi A., Adcock I.M. and Balbi B. (2009). Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax 64, 968-975.
13. Domagala-Kulawik J., Guzman J. and Costabel U. (2003). Immune cells in Bronchoalveolar Lavage in Peripheral Lung Cancer-Analysis of 140 cases. Respiration 70, 43-48.
14. Finkelstein R., Fraser R.S., Ghezzo H. and Cosio M.G. (1995). Alveolar inflammation and its relation to emphysema in smokers. Am. J. Respir. Crit. Care. Med. 152, 1666-1672.
15. Focosi D. and Petrini M. (2007). CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunction. J. Clin. Oncol. 25, 1289-1291.
16. + T lymphocytes and functional immune deficiency. J. Leukoc. Biol. 87, 107-16.
17. +) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J. Immunol. 184, 6504-6513.
18. Gizycki M.J., Hattotuwa K.L., Barnes N. and Jeffery P.K. (2002). Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax 57, 799-803.
19. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) (2009). Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. http://www.goldcopd.org
20. Grashoff W.F., Sont J.K., Sterk P.J., Hiemstra P.S., de Boer W.I., Stolk J., Han J. and van Krieken J.M. (1997). Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages. Am. J. Pathol. 151, 1785-1790.
21. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., Cherniak R.M., Rogers R.M., Sciurba F.C., Coxson H.O. and Paré P.D. (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653.
22. Hoshino M. and Nakamura Y. (1996). Anti-inflammatory effects of inhaled beclomethasone dipropionate in nonatopic asthmatics. Eur. Respir. J. 9, 696-702.
23. Irmler M., Hertig S., MacDonald H.R., Sadoul R., Becherer J.D., Proudfoot A., Solari R. and Tschopp J. (1995). Granzyme A is an interleukin 1 beta-converting enzyme. J. Exp. Med. 181, 1917-1922.
24. Kijima M., Yamaguchi T., Ishifune C., Maekawa Y., Koyanagi A., Yagita H., Chiba S., Kishihara K., Shimada M. and Yasutomo K. (2008). Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. Proc. Natl. Acad. Sci. USA 105, 7010-7015.
25. Lams B.E., Sousa A.R., Rees P.J. and Lee T.H. (1998). Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 158, 1518-1523.
26. Liles W.C., Kiener P.A., Ledbetter J.A., Aruffo A. and Klebanoff S.J. (1996). Differential expression of Fas (CD95) and Fas ligand on normal human phagocytesimplications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429-440.
27. López A.D., Shibuya K., Rao C., Mathers C.D., Hansell A.L., Held L.S., Schmid V. and Buist S. (2006). Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 27, 397-412.
28. Majó J., Ghezzo H. and Cosio M.G. (2001). Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Respir. J 17, 946-953.
29. Murugan V. and Peck M.J. (2009). Signal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease. Exp. Lung Res. 35, 439-485.
30. Nguyen L.T., Lim S., Oates T. and Chung K.F. (2005). Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma. Respir. Med. 99, 200-207.
31. O'Donnell R., Breen D., Wilson S. and Djukanovic R. (2006). Inflammatory cells in the airways in COPD. Thorax 61, 448-454.
32. + T lymphocytes with FEV1. (1997). Am. J. Respir. Crit. Care. Med. 155, 852-857.
33. Olloquequi J., Ferrer J., Montes J.F., Rodríguez E., Montero M.A. and García-Valero J. (2010). Differential lymphocyte infiltration in small airways and lung parenchyma in COPD patients. Respir. Med. 104, 1310-1318.
34. + cells in pulmonary lymphoid follicles of COPD patients. Eur. Respir. J. 37, 1-10.
35. Palmer B.E., Mack D.G., Martin A.K., Maier L.A. and Fontenot A.P. (2007). CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease. J. Allergy Clin. Immunol. 120, 184-191.
36. Pilette C., Godding V., Kiss R., Delos M., Verbeken E., Decaestecker C., De Paepe K., Vaerman J.P., Decramer M. and Sibille Y. (2001). Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 163, 185-194.
37. Reppert S., Boross I., Koslowski M., Türeci Ö., Lehr H.A., Glimcher L.H. and Finotto S. (2010). The role of NFATc1 in tumor T cell responses to lung cancer. J. Immunol. 184, 101.6
38. Reid D.W., Wen Y., Johns D.P., Williams T.J., Ward C. and Walters E.H. (2008). Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related. Respirology 13, 799-809.
39. Retamales I., Elliott W.M., Meshi B., Coxson H.O., Pare P.D., Sciurba F.C., Rogers R.M., Hayashi S. and Hogg J.C. (2001). Amplification of inflammation and its association with latent adenoviral infection. Am. J. Respir. Crit. Care. Med.164, 469-473.
40. Saetta M., Di Stefano A., Turato G., Facchini F.M., Corbino L., Mapp C.E., Maestrelli P., Ciaccia A. and Fabbri L.M. (1998). CD8+ Tlymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 157, 822-826.
41. +ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 160, 711-717.
42. Sethi S. and Murphy T.F. (2008). Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 2355-2365.
43. Sower L.E., Froelich C.J., Allegretto N., Rose P.M., Hanna W.D. and Klimpel G.R. (1996a). Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin. J. Immunol. 156, 2585-2590.
44. Sower L.E., Klimpel G.R., Hanna W., Froelich C.J. (1996b). Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. Cell Immunol. 171, 159-163.
45. Tanni S.E., Pelegrino N.R., Angeleli A.Y., Correa C. and Godoy I. (2010). Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J. Inflamm. (Lond). 7, 29.
46. Tarazona R., DelaRosa O., Alonso C., Ostos B., Espejo J., Peña J. and Solana R. (2000). Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech. Ageing Dev. 121, 77-88.
47. Thurlbeck W.M., Dunnill M.S., Hartung W., Heard B.E., Heppelston A.G. and Ryden R.C. (1970). A comparison of three methods of measuring emphysema. Hum. Pathol. 1, 215-226.
48. Tsoumakidou M., Koutsopoulos A.V., Tzanakis N., Dambaki K., Tzortzaki E., Zakynthinos S., Jeffery P.K. and Siafakas N.M. (2009). Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest 136, 726-733.
49. Turato G., Zuin R., Miniati M., Baraldo S., Rea F., Beghé B., Monti S., Formichi B., Boschetto P., Harari S., Papi A., Maestrelli P., Fabbri L.M. and Saetta M. (2002). Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am. J. Respir. Crit. Care. Med. 166, 105-110.
50. Urbanowicz R.A., Lamb J.R., Todd I., Corne J.M. and Fairclough L.C. (2010). Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients. Respir. Res. 11, 76.
51. Van Pottelberge G.R., Bracke K.R., Demedts I.K., De Rijck K., Reinartz S.M., van Drunen C.M., Verleden G.M., Vermassen F.E., Joos G.F. and Brusselle G.G. (2010). Selective accumulation of langerhanstype dendritic cells in small airways of patients with COPD. Respir. Res. 11, 35.
52. Vassallo R., Walters P.R., Lamont J., Kottom T.J., Yi E.S. and Limper A.H. (2010). Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study. Respir. Res. 11, 45.
53. Vernooy J.H., Möller G.M., van Suylen R.J., van Spijk M.P., Cloots R.H., Hoet P.H., Pennings H.J. and Wouters E.F. (2007). Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 175, 464-472.
54. Yildiz F., Kaur A.C., Ilgazli A., Celikoglu M., Kaçar Ozkara S., Paksoy N. and Ozkarakafl O. (2000). Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease. Respiration 67, 71-76.